Advertisement
last updated on: 18 July 2016

GlaxoSmithKline Saudi Arabia Limited

Also known as: GSAL

fast facts

Country Saudi Arabia Ownership Type Private

Contact details

Primary address
Business Park Building
Corniche Road
22nd Floor
55852
Saudi Arabia
Jeddah
21544
  • Tel: +966 12-653-6666
  • Fax: +966 12-653-6660
  • Email:
Region
Makkah

Zawya industry classifications

SECTOR (Definitions) INDUSTRY (Expand All)
  • Health Care
    1. Pharmaceuticals
      1. Pharmaceuticals Suppliers
        1. Branded Drugs (Primary Industry)
        2. Generic Drugs
        3. Other Pharmaceuticals Suppliers
        4. Vitamins and Nutritionals

Officers

  • Name availableChairman and director representing Banaja Holdings
  • Name availableDirector representing Banaja Holdings
  • Name availablePresident
  • Name availableGeneral Manager and Vice President
  • Name availableFinance Director
  • Name availableMarketing Director
  • Name availableSales Director
  • Name availableMedical Director
  • Name availableVaccines Director
  • Name availableFactory Manager
  • Name availableProcurement Manager
  • Name availableTraining Manager
  • Name availableInformation Technology Manager

To get the full company information along with officer names and contact,
upgrade to Zawya Business Development.

Company information provided by © 2016 Zawya

Zawya's analysts update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Our researchers then validate this information and source further information by contacting the companies directly.

Related news

Saudi pharmaceutical market value forecast to rise to SR14bn

The Saudi pharmaceutical market is the largest in the Gulf Cooperation Council (GCC). The vast majority of the market is currently provided by imports, mainly comprised of patented and over-the- counter (OTC) drugs.

Arab News - 30-Jan-2011
Advertisement
Discover Thomson Reuters

Top Business News